http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2020013097-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2400-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2400-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96455 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2440-38 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2019-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2020013097-A1 |
| titleOfInvention | Prostate cancer-specific sugar chains and testing methods using them |
| abstract | By analyzing the PSA-modifying sugar chains in the sample and detecting the abundance of multisialylated LacdiNAc structures, especially GlycanID: 7512, GlycanID: 7603, GlycanID: 7612, and / or GlycanID: 7613, the prostate gland Provide an inspection method to identify the prostate. Furthermore, by calculating the PSA G-index from the relative abundance of GlycanID: 7512 and / or GlycanID: 7603, it is possible to detect prostate cancer with good specificity even in patients with PSA value gray zone. It became. |
| priorityDate | 2018-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.